Amgen Inc (NASDAQ:AMGN)
| 227.57 Delayed Data As of Jan 21 |  -1.33 / -0.58%Today’s Change | 198.64 Today|||52-Week Range 276.69 | +1.16% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 228.90 |
| Today’s open | 230.60 |
| Day’s range | 227.36 - 231.46 |
| Volume | 219,353 |
| Average volume (3 months) | 2,777,999 |
| Market cap | $128.3B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -4.37% |
| Earnings growth (this year) | +1.62% |
| Earnings growth (next 5 years) | +6.29% |
| Revenue growth (last year) | +8.53% |
| P/E ratio | 23.5 |
| Price/Sales | 5.37 |
| Price/Book | 14.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +0.69 | +1.02% |
| MRNAModerna Inc | -7.38 | -4.41% |
| ILMNIllumina Inc | -14.51 | -3.81% |
| BIIBBiogen | -5.41 | -2.39% |
Data as of 4:58pm ET, 01/21/2022
Financials
| Next reporting date | February 8, 2022 |
| EPS forecast (this quarter) | $4.07 |
| Annual revenue (last year) | $25.2B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 28.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
